Connection
Lisa Bero to Drug Approval
This is a "connection" page, showing publications Lisa Bero has written about Drug Approval.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.112 |
|
|
|
-
Schroll J, Bero L. Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev. 2015 Apr 20; 4:ED000098.
Score: 0.502
-
Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med. 2008 Nov 25; 5(11):e217; discussion e217.
Score: 0.322
-
Schroll JB, Abdel-Sattar M, Bero L. The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reports. J Clin Epidemiol. 2015 Jan; 68(1):102-7.
Score: 0.120
-
Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ. 2012 Jan 03; 344:d7202.
Score: 0.100
-
Nguyen NT, Cook DM, Bero LA. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study. Clin Ther. 2006 Aug; 28(8):1231-1243.
Score: 0.069